HAG
HighPoint Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $830K | Sell |
1,581
-43
| -3% | -$22.6K | 0.04% | 273 |
|
|
2025
Q1 | $924K | Sell |
1,624
-173
| -10% | -$98.4K | 0.05% | 246 |
|
|
2024
Q4 | $1.2M | Sell |
1,797
-296
| -14% | -$198K | 0.07% | 219 |
|
|
2024
Q3 | $2.2M | Buy |
2,093
+25
| +1% | +$26.3K | 0.13% | 135 |
|
|
2024
Q2 | $2.23M | Buy |
2,068
+210
| +11% | +$226K | 0.13% | 129 |
|
|
2024
Q1 | $1.82M | Buy |
1,858
+49
| +3% | +$47.9K | 0.13% | 135 |
|
|
2023
Q4 | $1.74M | Buy |
+1,809
| New | +$1.74M | 0.12% | 134 |
|
|
2022
Q2 | $474K | Buy |
+798
| New | +$474K | 0.05% | 301 |
|
|
2021
Q3 | $606K | Buy |
1,002
+616
| +160% | +$373K | 0.06% | 270 |
|
|
2021
Q2 | $216K | Buy |
+386
| New | +$216K | 0.02% | 484 |
|
|
2021
Q1 | – | Sell |
-601
| Closed | -$295K | – | 536 |
|
|
2020
Q4 | $295K | Buy |
601
+200
| +50% | +$98.2K | 0.04% | 354 |
|
|
2020
Q3 | $236K | Buy |
401
+14
| +4% | +$8.24K | 0.04% | 317 |
|
|
2020
Q2 | $236K | Buy |
387
+19
| +5% | +$11.6K | 0.05% | 286 |
|
|
2020
Q1 | $208K | Buy |
+368
| New | +$208K | 0.05% | 290 |
|
|
2019
Q4 | – | Sell |
-348
| Closed | -$118K | – | 454 |
|
|
2019
Q3 | $118K | Buy |
348
+1
| +0.3% | +$339 | 0.03% | 431 |
|
|
2019
Q2 | $102K | Buy |
+347
| New | +$102K | 0.02% | 457 |
|
|
2017
Q3 | – | Sell |
-7,380
| Closed | -$424K | – | 289 |
|
|
2017
Q2 | $424K | Hold |
7,380
| – | – | 0.14% | 179 |
|
|
2017
Q1 | $424K | Buy |
+7,380
| New | +$424K | 0.14% | 179 |
|